Variant report

rSNPs within LD-proxies of this variant (count:20)

rs_ID	r²[population]
rs16889013	1.00[AMR][1000 genomes]
rs55753611	1.00[ASN][1000 genomes]
rs57703266	1.00[ASN][1000 genomes]
rs59526803	1.00[AMR][1000 genomes]
rs60697895	0.92[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[ASN][1000 genomes]
rs60843964	1.00[ASN][1000 genomes]
rs7012684	0.88[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[ASN][1000 genomes]
rs73701495	1.00[ASN][1000 genomes]
rs73701497	1.00[ASN][1000 genomes]
rs73701498	1.00[ASN][1000 genomes]
rs73701500	1.00[ASN][1000 genomes]
rs73701501	1.00[ASN][1000 genomes]
rs73701502	1.00[ASN][1000 genomes]
rs73703403	0.88[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[ASN][1000 genomes]
rs73703405	1.00[ASN][1000 genomes]
rs73703406	1.00[ASN][1000 genomes]
rs73703408	1.00[ASN][1000 genomes]
rs73703409	1.00[ASN][1000 genomes]
rs7840707	1.00[ASN][1000 genomes]
rs7840992	1.00[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:2 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv530386	chr8:117509968-118391406	Enhancers Active TSS Weak transcription Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	37 gene(s)	inside rSNPs	diseases
2	nsv831434	chr8:117784467-117977825	Flanking Active TSS Genic enhancers Weak transcription Enhancers Active TSS Bivalent/Poised TSS Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	17 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:16 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:117840600-117845800	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
2	chr8:117840800-117859400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr8:117841000-117856800	Weak transcription	HUES64 Cell Line	embryonic stem cell
4	chr8:117841600-117845400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr8:117844000-117845600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
6	chr8:117844600-117856400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr8:117845200-117845400	Flanking Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
8	chr8:117845200-117845400	Flanking Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
9	chr8:117845200-117845400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr8:117845200-117845600	Enhancers	A549	lung
11	chr8:117845200-117846000	Enhancers	ES-I3 Cell Line	embryonic stem cell
12	chr8:117845200-117846000	Enhancers	HMEC	breast
13	chr8:117845200-117846000	Enhancers	HUVEC	blood vessel
14	chr8:117845200-117846000	Enhancers	NH-A	brain
15	chr8:117845200-117846200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
16	chr8:117845200-117846800	Enhancers	HepG2	liver

Quick Search: